Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Prostate
Study Phase
Phase 3
Study Completion Date
January 2012
NCT00988208Uploaded 03-11-2014
Available for Download
PDS UID: Prostat_Celgene_2009_90
A Phase 3 Study to Evaluate the Efficacy and Safety of Docetaxel and Prednisone With or Without Lenalidomide in Subjects With Castrate-Resistant Prostate Cancer (CRPC)
PDS UID: Prostat_Multipl_2018_234Go to Study
Enhancing the Analytic Capacity of Prostate_Celgene_2009_90 using a Statistical Linkage Method to Append Socioeconomic and Health Care Access Variables from the Medical Expenditure Panel Survey
Files:
PROTOCOLCC-5013-PC-002 Final Protocol_Redacted.pdf
CRFblankCRF_RedactedMAINSAIL.pdf
DATA (COMPARATOR ARM)PC002_De-id_Database 2.zip